Top

Current Treatment Options in Oncology

Published in:

01-06-2008 | Malignant Mesothelioma

Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis

Authors: Haining Yang, PhD, Joseph R. Testa, PhD, Michele Carbone, MD, PhD

Published in: Current Treatment Options in Oncology | Issue 2-3/2008

Title: Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis
Authors: Haining Yang, PhD
Joseph R. Testa, PhD
Michele Carbone, MD, PhD
Publication date: 01-06-2008
Publisher: Springer US
Published in: Current Treatment Options in Oncology / Issue 2-3/2008
Print ISSN: 1527-2729
Electronic ISSN: 1534-6277
DOI: https://doi.org/10.1007/s11864-008-0067-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2-3/2008

Pain Management for Hepatobiliary Cancer

Treatment of Malignant Ascites

Systemic Treatments for Mesothelioma: Standard and Novel

Herbs and Other Botanicals in Cancer Patient Care

Acupuncture as an Evidence-Based Option for Symptom Control in Cancer Patients

Exercise in Prevention and Management of Cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer